AstraZeneca Stock News

The companies commit to bring cutting-edge liquid biopsy testing to 20 institutions globally over the next 12 months BOSTON and ROLLE, Switzerland , Sept. 10, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced a new milestone in the global introduction of the liquid biopsy test MSK-ACCESS...

Shares in AstraZeneca PLC (LSE:AZN) were the biggest drag on the FTSE 100 on Tuesday, falling over 4.5% on the back of some disappointing results from a trial of a lung cancer drug. Late-stage trial results of the TROPION-Lung01 showed that the overall survival rate from the new drug “did not reach statistical significance,” the company said.

AstraZeneca shares fell more than 5% Tuesday morning, the biggest one-day drop in seven months, after the British pharmaceutical giant announced disappointing lung cancer drug trial results.

London-listed shares of AstraZeneca fell on Tuesday after results from the company's lung cancer trials showed that its experimental precision drug did not significantly improve overall survival results for patients.

Detailed results from one of AstraZeneca's key lung cancer trials released on Monday showed that its experimental precision drug did not significantly improve overall survival results for patients in the trial.

AstraZeneca's robust pipeline and plentiful growth opportunities make it one of the best healthcare stocks to buy. Chewy is coming off a solid quarter, and there's still more growth ahead in the pet food industry.

Five current and former AstraZeneca (AZN) employees have been detained by police in China in connection with alleged violations of data privacy laws and for importing an unapproved cancer drug, according to a Bloomberg report.

AstraZeneca PLC (LSE:AZN) shares fell 3.5% after it confirmed that five current and former employees in China are being held by police for questioning. The individuals, all Chinese nationals, worked in the company's oncology division marketing cancer treatments, with the police detentions made in the city of Shenzhen earlier this summer.